Analysis-Weight loss drug candidates multiply, spurring hopes of better outcomes, lower costs
By Deena Beasley SAN DIEGO New data on weight loss drugs that could compete with Novo Nordisk's Wegovy
2023-06-27 20:45
Novo Nordisk says obesity pill leads to 15% weight loss; availability "to be determined"
By Deena Beasley SAN DIEGO Drugmaker Novo Nordisk on Sunday said a late-stage trial found that a high-dose
2023-06-26 09:26
Experimental Lilly pill, Mounjaro both lead to 15% weight loss in clinical trials
By Deena Beasley (Reuters) -In a mid-stage trial, the highest dose of Eli Lilly's experimental pill orforglipron led to 14.7%
2023-06-24 08:23
Britain to explore wider access to weight-loss drugs in two-year pilot
By Ludwig Burger and Maggie Fick (Reuters) -The British government will launch a pilot programme to explore how new injectable
2023-06-07 17:49
Weight-loss drug pioneers aim to jump on Wegovy bandwagon
By Jennifer Rigby DUBLIN Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing
2023-05-23 13:19
Novo Nordisk: trial data of oral weight-loss drug comparable to Wegovy
By Louise Rasmussen COPENHAGEN (Reuters) -Novo Nordisk said on Monday data from a late-stage trial showed an oral version of
2023-05-23 00:50
Obesity drug brings heart health benefit alongside weight loss - study
By Jennifer Rigby DUBLIN Taking Novo Nordisk’s new obesity drug may help reduce the risk of heart disease
2023-05-20 06:16
Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review
By Jennifer Rigby LONDON New highly-effective weight loss drugs such as Novo Nordisk's Wegovy are not a “silver
2023-05-12 16:46
Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
By Ludwig Burger FRANKFURT Zealand Pharma and partner Boehringer Ingelheim said their experimental obesity drug achieved up to
2023-05-10 15:58
How promising are new drugs to treat obesity and who should — and shouldn't — use them? Our medical analyst explains
How do the diabetes drugs semaglutide and tirzepatide work to reduce obesity? How promising are they to treat obesity? What are their side effects? Who is eligible to take them? CNN Medical Analyst Dr. Leana Wen answers these questions.
2023-05-09 05:50